Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: A meta-analysis

Pediatrics

Volumn 129, Issue 4, 2012, Pages

  Rodday, Angie Mae ^a   Triedman, John K ^b,c   Alexander, Mark E ^b,c   Cohen, Joshua T ^a,d   Ip, Stanley ^a,d   Newburger, Jane W ^b,c   Parsons, Susan K ^a,d   Trikalinos, Thomas A ^a,d   Wong, John B ^a,d   Leslie, Laurel K ^a,d  

^a TUFTS MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ECG screening; Hypertrophic cardiomyopathy; Long QT syndrome; Sudden cardiac death; Wolff Parkinson White syndrome

Indexed keywords

ADOLESCENT; ADULT; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTERMETHOD COMPARISON; LONG QT SYNDROME; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REVIEW; SCHOOL CHILD; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; WOLFF PARKINSON WHITE SYNDROME;

CHILD; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HEART DISEASES; HUMANS; INCIDENCE; MASS SCREENING; PREVALENCE; WORLD HEALTH;

EID: 84859375367     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-0643     Document Type: Review

References (56)

1. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296(13):1593-1601 (Pubitemid 44515020)
2. Berger S, Utech L, Fran Hazinski M. Sudden death in children and adolescents. Pediatr Clin North Am. 2004;51(6):1653-1677, ix-x (Pubitemid 39550508)
3. Wheeler MT, Heidenreich PA, Froelicher VF, Hlatky MA, Ashley EA. Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med. 2010;152(5):276-286
4. Denchev P, Kaltman JR, Schoenbaum M, Vitiello B. Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/hyperactivity disorder. Circulation. 2010;121(11):1329-1337
5. Tanaka Y, Yoshinaga M, Anan R, et al. Usefulness and cost effectiveness of cardiovascular screening of young adolescents. Med Sci Sports Exerc. 2006;38(1):2-6 (Pubitemid 43062949)
6. Kaltman JR, Thompson PD, Lantos J, et al. Screening for sudden cardiac death in the young: report from a National Heart, Lung, and Blood Institute working group. Circulation. 2011;123(17):1911-1918
7. Vetter VL, Elia J, Erickson C, et al American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee; American Heart Association Council on Cardiovascular Nursing. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/ hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation. 2008;117(18):2407-2423
8. Pastor PN, Reuben CA. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004 -2006. National Center for Health Statistics. Vital Health Stat. 2008; 10(237)
9. Perrin JM, Friedman RA, Knilans TK; Black Box Working Group; Section on Cardiology and Cardiac Surgery. Cardiovascular monitoring and stimulant drugs for attention-deficit/ hyperactivity disorder. Pediatrics. 2008;122(2):451-453
10. Maron BJ, Thompson PD, Ackerman MJ, et al American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007; 115(12):1643-1655 (Pubitemid 46648650)
11. Hennekens CH, Buring JE, Mayrent SL. Epidemiology in Medicine. 1st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1987
12. Berger S, Dhala A, Friedberg DZ. Sudden cardiac death in infants, children, and adolescents. Pediatr Clin North Am. 1999;46(2): 221-234 (Pubitemid 29177697)
13. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120(18):1761-1767
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3): 177-188 (Pubitemid 17189972)
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558 (Pubitemid 34746062)
16. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20(19):2865-2884 (Pubitemid 32923212)
17. Gatsonis C, Paliwal P. Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. AJR Am J Roentgenol. 2006;187(2):271-281 (Pubitemid 44148267)
18. Dukic V, Gatsonis C. Meta-analysis of diagnostic test accuracy assessment studies with varying number of thresholds. Biometrics. 2003;59(4):936-946 (Pubitemid 38021222)
19. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92(4):785-789
20. Triedman JK. Management of asymptomatic Wolff-Parkinson-White syndrome. Heart. 2009; 95(19):1628-1634
21. Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. West Sussex, England: John Wiley & Sons Ltd; 2009
22. Joseph L, Gyorkos TW, Coupal L. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. Am J Epidemiol. 1995;141(3):263-272
23. Arola A, Jokinen E, Ruuskanen O, et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol. 1997;146 (5):385-393 (Pubitemid 27377515)
24. Colivicchi F, Ammirati F, Santini M. Epidemiology and prognostic implications of syncope in young competing athletes. Eur Heart J. 2004;25(19):1749-1753 (Pubitemid 39286641)
25. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998; 339(6):364-369 (Pubitemid 28363798)
26. Maron BJ, Mathenge R, Casey SA, Poliac LC, Longe TF. Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities. J Am Coll Cardiol. 1999;33(6): 1590-1595
27. Niimura I, Maki T. Sudden cardiac death in childhood. Jpn Circ J. 1989;53(12):1571-1580 (Pubitemid 20267791)
28. Nistri S, Thiene G, Basso C, Corrado D, Vitolo A, Maron BJ. Screening for hypertrophic cardiomyopathy in a young male military population. Am J Cardiol. 2003;91 (8):1021-1023, A8
29. Zou Y, Song L, Wang Z, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am J Med. 2004;116 (1):14-18 (Pubitemid 38050021)
30. Chiu SN, Wang JK, Wu MH, et al Taipei Pediatric Cardiology Working Group. Cardiac conduction disturbance detected in a pediatric population. J Pediatr. 2008;152(1):85-89
31. Kobza R, Roos M, Niggli B, et al. Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts. Heart Rhythm. 2009;6(5):652-657
32. Autore C, Fragola PV, Picelli A, et al. Equivocal and borderline myocardial hypertrophy in relatives of patients with hypertrophic cardiomyopathy: possible implications in genetics of the disease. Cardiology. 1988;75 (5):348-356 (Pubitemid 18269267)
33. Charron P, Dubourg O, Desnos M, et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation. 1997;96(1):214-219 (Pubitemid 27298423)
34. Charron P, Dubourg O, Desnos M, et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J. 1998;19(9):1377-1382 (Pubitemid 28427140)
35. Charron P, Forissier JF, Amara ME, et al. Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population. Int J Cardiol. 2003;90(1):33-38, discussion 38-40
36. Dipchand AI, McCrindle BW, Gow RM, Freedom RM, Hamilton RM. Accuracy of surface electrocardiograms for differentiating children with hypertrophic cardiomyopathy from normal children. Am J Cardiol. 1999;83 (4):628-630, A10
37. Fragola PV, Borzi M, Cannata D. The spectrum of echocardiographic and electrocardiographic abnormalities in nonaffected relatives of patients with hypertrophic cardiomyopathy: a transverse and longitudinal study. Cardiology. 1993;83(5-6):289-297 (Pubitemid 24024554)
38. Konno T, Shimizu M, Ino H, et al. Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis. Eur Heart J. 2004;25(3): 246-251 (Pubitemid 38235162)
39. Potter SL, Holmqvist F, Platonov PG, et al. Detection of hypertrophic cardiomyopathy is improved when using advanced rather than strictly conventional 12-lead electrocardiogram. J Electrocardiol. 2010;43(6): 713-718
40. Ryan MP, Cleland JG, French JA, et al. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol. 1995;76(10):689-694
41. Ho CY, Sweitzer NK, McDonough B, et al. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation. 2002;105(25):2992-2997 (Pubitemid 34693832)
42. Benhorin J, Merri M, Alberti M, et al. Long QT syndrome. New electrocardiographic characteristics. Circulation. 1990;82(2):521-527
43. Kaufman ES, Priori SG, Napolitano C, et al. Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members. J Cardiovasc Electrophysiol. 2001; 12(4):455-461 (Pubitemid 32324661)
44. Miller MD, Porter CB, Ackerman MJ. Diagnostic accuracy of screening electrocardiograms in long QT syndrome I. Pediatrics. 2001;108 (1):8-12 (Pubitemid 32594775)
45. Moennig G, Schulze-Bahr E, Wedekind H, et al. Clinical value of electrocardiographic parameters in genotyped individuals with familial long QT syndrome. Pacing Clin Electrophysiol. 2001;24(4 pt 1):406-415 (Pubitemid 32374860)
46. Neyroud N, Maison-Blanche P, Denjoy I, et al. Diagnostic performance of QT interval variables from 24-h electrocardiography in the long QT syndrome. Eur Heart J. 1998;19 (1):158-165 (Pubitemid 28112313)
47. Swan H, Saarinen K, Kontula K, Toivonen L, Viitasalo M. Evaluation of QT interval duration and dispersion and proposed clinical criteria in diagnosis of long QT syndrome in patients with a genetically uniform type of LQT1. J Am Coll Cardiol. 1998;32(2):486-491 (Pubitemid 28396501)
48. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med. 1992;327 (12):846-852
49. Viskin S, Postema PG, Bhuiyan ZA, et al. The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol. 2010;55(18): 1955-1961
50. Wong JA, Gula LJ, Klein GJ, Yee R, Skanes AC, Krahn AD. Utility of treadmill testing in identification and genotype prediction in long-QT syndrome. Circ Arrhythm Electrophysiol. 2010;3(2):120-125
51. Meyer KB, Pauker SG. Screening for HIV: can we afford the false positive rate? N Engl J Med. 1987;317(4):238-241 (Pubitemid 17103107)
52. Harris RP, Helfand M, Woolf SH, et al Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(suppl 3):21-35 (Pubitemid 33732964)
53. Hill AC, Miyake CY, Grady S, Dubin AM. Accuracy of interpretation of preparticipation screening electrocardiograms. J Pediatr. 2011;159(5):783-788
54. Young PC. The morbidity of cardiac non-disease revisited. Is there lingering concern associated with an innocent murmur? Am J Dis Child. 1993;147(9):975-977 (Pubitemid 23261998)
55. Bergman AB, Stamm SJ. The morbidity of cardiac nondisease in schoolchildren. N Engl J Med. 1967;276(18):1008-1013
56. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 1996;276(3):199-204